We are live on ! Find out more
CA

Capital Advantage Portfolio holdings

AUM $834M Turnover 14.46%
1-Year Est. Return 15.6%
This Fund
S&P 500
This Quarter Est. Return
+0.17%
1 Year Est. Return
+15.6%
3 Year Est. Return
+49.19%
5 Year Est. Return
+46.21%
10 Year Est. Return
–
AUM
$243M
AUM Growth
+$50.7M
Cap. Flow
+$51M
Cap. Flow %
21.03%
Top 10 Hldgs %
70.13%
Holding
71
New
15
Increased
22
Reduced
14
Closed
4
Avg Time Held
0.7 years
Top 10 Avg Time Held
0.6 years
Top 20 Avg Time Held
0.6 years
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MMM icon
51
3M
MMM
$85.4B
$259K 0.11%
1,883
– –
2013 Q4
4 quarters
SYK icon
52
Stryker
SYK
$112B
$255K 0.11%
2,705
– –
2013 Q4
4 quarters
AXP icon
53
American Express
AXP
$209B
$254K 0.1%
2,729
– –
2014 Q2
2 quarters
HPQ icon
54
HP
HPQ
$28B
$250K 0.1%
+13,696
New +$230K
2014 Q4
0 quarters
VFH icon
55
Vanguard Financials ETF
VFH
$13B
$248K 0.1%
4,992
– –
2013 Q4
4 quarters
DIS icon
56
Walt Disney
DIS
$192B
$244K 0.1%
2,596
– –
2014 Q1
3 quarters
SPY icon
57
State Street SPDR S&P 500 ETF Trust
SPY
$811B
$241K 0.1%
+1,172
New +$236K
2014 Q4
0 quarters
SCHD icon
58
Schwab US Dividend Equity ETF
SCHD
$114B
$237K 0.1%
+17,808
New +$233K
2014 Q4
0 quarters
BMY icon
59
Bristol-Myers Squibb
BMY
$126B
$234K 0.1%
3,965
– –
2014 Q3
1 quarter
BA icon
60
Boeing
BA
$147B
$229K 0.09%
1,765
– –
2014 Q1
3 quarters
SCHA icon
61
Schwab U.S Small- Cap ETF
SCHA
$21.4B
$217K 0.09%
+15,760
New +$209K
2014 Q4
0 quarters
SCHE icon
62
Schwab Emerging Markets Equity ETF
SCHE
$12.6B
$214K 0.09%
+8,954
New +$224K
2014 Q4
0 quarters
TWTR
63
DELISTED
Twitter, Inc.
TWTR
$213K 0.09%
5,941
– –
2014 Q2
2 quarters
SHY icon
64
iShares 1-3 Year Treasury Bond ETF
SHY
$26.9B
$212K 0.09%
2,505
-2,268
-48% -$192K
2013 Q4
4 quarters
MDT icon
65
Medtronic
MDT
$123B
$207K 0.09%
+2,864
New +$199K
2014 Q4
0 quarters
PHYS icon
66
Sprott Physical Gold
PHYS
$14.9B
– –
-10,768
Closed -$107K –
SLB icon
67
SLB Ltd
SLB
$70.5B
– –
-2,019
Closed -$205K –
TEVA icon
68
Teva Pharmaceutical Industries Limited
TEVA
$48.3B
– –
-5,351
Closed -$288K –
RDS.A
69
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
– –
-3,083
Closed -$219K –

Similar funds

Capital Advantage's Q4 2014 Portfolio in Review

As of Q4 2014, Capital Advantage held 71 positions worth $243M, up 26% from $192M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Capital Advantage deployed $51M of net new capital in Q4 2014, opening 15 new positions and adding to 22 existing holdings. Its largest new stake was Vanguard Morningstar Mega Cap Value ETF: 296,319 shares worth $18M.

By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, up from 87% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Guggenheim BulletShares 2016 Corporate Bond ETF, an estimated $4.1M trimmed.

  • Capital Advantage's largest Q4 2014 buy was Vanguard Morningstar Mega Cap Value ETF: 296,319 shares worth $18M.
  • Capital Advantage added most to iShares Core S&P 500 ETF in Q4 2014, an estimated $11.3M increase.
  • Capital Advantage's biggest Q4 2014 reduction was Guggenheim BulletShares 2016 Corporate Bond ETF, cutting an estimated $4.1M.
  • Capital Advantage fully exited Teva Pharmaceutical Industries Limited in Q4 2014, selling an estimated $288K.
  • Capital Advantage's ten largest holdings make up 70% of its $243M portfolio in Q4 2014.
  • Capital Advantage opened 15 new positions and closed 4 in Q4 2014.
  • Capital Advantage's portfolio value rose 26% quarter-over-quarter to $243M.

Based on Capital Advantage's 13F filing for Q4 2014, filed 15 May 2015.